Expand VNRX Menu
VNRX MENU

VNRX Latest Press Releases

-- August 12, 2026 --

Volition Demonstrates Utility of Rapid, Point-of-Care Finger-Prick Test in Sepsis Patients PRNewswire 8:17 AM

-- August 11, 2026 --

VolitionRx Limited Schedules Second Quarter 2026 Earnings Conference Call and Business Update PRNewswire 4:10 PM

-- August 5, 2026 --

Volition Reports Publication of First Peer Reviewed Paper on New Capture-Seq Liquid Biopsy Technology PRNewswire 8:17 AM

-- July 30, 2026 --

Volition Advances Nu.Q NETs Platform Towards Commercialization PRNewswire 8:17 AM

-- July 7, 2026 --

VolitionRx Announces Data Showing the Prognostic Value of its Nu.Q Cancer Test PRNewswire 8:17 AM

-- June 17, 2026 --

VolitionRx Announces Collaboration with Sysmex PRNewswire 8:15 AM

-- June 7, 2026 --

VolitionRx Announces Pricing of $4.6 Million Public Offering PRNewswire 6:30 PM

-- June 3, 2026 --

VolitionRx Files New Patent Protecting its Nu.Q NETs Test for Ebola Triage and Treatment Monitoring PRNewswire 8:12 AM

-- May 27, 2026 --

VolitionRx Highlights Commercial Momentum and Multi-Pillar Execution Across $27+ Billion Total Addressable Markets PRNewswire 8:17 AM

-- May 14, 2026 --

VolitionRx Limited Announces First Quarter 2026 Financial Results and Business Update PRNewswire 4:10 PM

-- May 11, 2026 --

VolitionRx Limited Schedules First Quarter 2026 Earnings Conference Call and Business Update PRNewswire 8:19 AM

-- April 29, 2026 --

Volition Announces Breakthrough Finger-Prick Detection of Nucleosomes; Expanding Global Market Potential for Sepsis Testing PRNewswire 8:17 AM

-- April 23, 2026 --

VolitionRx Announces Acceptance of Compliance Plan by NYSE American PRNewswire 8:13 AM
VolitionRx Announces Acceptance of Compliance Plan by NYSE American PRNewswire 8:13 AM

-- April 20, 2026 --

Volition Launches rNuQ Webshop Broadening Product Range PRNewswire 7:30 AM

-- March 31, 2026 --

VolitionRx Limited Announces Full Fiscal Year 2025 Financial Results and Business Update PRNewswire 4:05 PM
VolitionRx Secures EUR 2.0 Million of Non-Dilutive Funding from Regional Government Agencies in Belgium PRNewswire 8:16 AM

-- March 30, 2026 --

Volition Announces Mayo Clinic Study Demonstrates Nu.Q Concentrations are Elevated in Trauma Patients PRNewswire 8:13 AM

-- March 26, 2026 --

Volition Announces Abstract Demonstrating Risk Stratification in Lung Cancer Presented at the European Lung Cancer Conference PRNewswire 8:17 AM

-- March 25, 2026 --

VolitionRx Limited Schedules Full Fiscal Year 2025 Earnings Conference Call and Business Update PRNewswire 4:12 PM
Volition Announces Detection of Over 95% of Early-Stage Cancers PRNewswire 8:17 AM

-- March 18, 2026 --

Volition Reports Breakthrough in Liquid Biopsy: Achievement of over 99% Purity in Isolating Cancer DNA PRNewswire 8:17 AM
Market Data Delayed 15 Minutes